Indication
Gastric cancer
Gastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma. Read more about Gastric cancer
75 drugs 61 manufacturers
Drugs that treat it
Common Gastric cancer therapies.
DOCETAXEL
DOCETAXEL
CAPECITABINE
DOCETAXEL
FLUOROURACIL
CAPECITABINE
DOCETAXEL
CAPECITABINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma.
It affects the upper gastrointestinal system and predominantly occurs in older adults, frequently developing through a prolonged inflammatory cascade associated with *Helicobacter pylori* infection, dietary exposures, or inherited genetic predispositions.
Pathophysiologically, it is broadly classified into intestinal and diffuse histological subtypes, characterized by glandular formation or diffuse, infiltrative signet-ring cells, respectively.
While early stages are typically asymptomatic or non-specific, disease progression is clinically characterized by persistent epigastric pain, early satiety, progressive dysphagia, hematemesis, melena, and profound involuntary weight loss.
- cancer.gov
Gastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma
- cancer.gov
Gastric cancer is a malignant neoplastic disease that originates in the mucosal lining of the stomach, most commonly manifesting as adenocarcinoma Pathophysiologically, it is broadly classified into intestinal and diffuse histological subtypes, characterized by glandular formation or diffuse, infiltrative signet-ring cells, respectively
- nih.gov
It affects the upper gastrointestinal system and predominantly occurs in older adults, frequently developing through a prolonged inflammatory cascade associated with *Helicobacter pylori* infection, dietary exposures, or inherited genetic predispositions Pathophysiologically, it is broadly classified into intestinal and diffuse histological subtypes, characterized by glandular formation or diffuse, infiltrative signet-ring cells, respectively
- nih.gov
It affects the upper gastrointestinal system and predominantly occurs in older adults, frequently developing through a prolonged inflammatory cascade associated with *Helicobacter pylori* infection, dietary exposures, or inherited genetic predispositions
- nih.gov
It affects the upper gastrointestinal system and predominantly occurs in older adults, frequently developing through a prolonged inflammatory cascade associated with *Helicobacter pylori* infection, dietary exposures, or inherited genetic predispositions While early stages are typically asymptomatic or non-specific, disease progression is clinically characterized by persistent epigastric pain, early satiety, progressive dysphagia, hematemesis, melena, and profound involuntary weight loss
- aafp.org
While early stages are typically asymptomatic or non-specific, disease progression is clinically characterized by persistent epigastric pain, early satiety, progressive dysphagia, hematemesis, melena, and profound involuntary weight loss
Personalize your experience
Follow Gastric cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.